All Stories

  1. Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes

    Article • PLoS ONE, July 2017, PLOS

    George Kalliolias

  2. The impact of disease activity and tumour necrosis factor‐α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis

    Article • Clinical & Experimental Immunology, April 2016, Wiley

    George Kalliolias

  3. TNF biology, pathogenic mechanisms and emerging therapeutic strategies

    Article • Nature Reviews Rheumatology, December 2015, Nature

    George Kalliolias

  4. Blood-Induced Arthropathy in Hemophilia: Mechanisms and Heterogeneity

    Article • Seminars in Thrombosis and Hemostasis, October 2015, Thieme Publishing Group

    George Kalliolias

  5. Prolonged Tumor Necrosis Factor α Primes Fibroblast-like Synoviocytes in a Gene-Specific Manner by Altering Chromatin

    Article • Arthritis & Rheumatology, December 2014, Wiley

    George Kalliolias

  6. Modulation of TNF-Induced Macrophage Polarization by Synovial Fibroblasts

    Article • The Journal of Immunology, July 2014, The American Association of Immunologists

    George Kalliolias

  7. Kinase inhibitors: A new tool for the treatment of rheumatoid arthritis

    Article • Clinical Immunology, July 2013, Elsevier

    George Kalliolias

  8. Tumor Necrosis Factor α Induces Sustained Signaling and a Prolonged and Unremitting Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts

    Article • Arthritis & Rheumatism, March 2013, Wiley

    George Kalliolias

  9. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis

    Article • Journal of Clinical Investigation, January 2013, American Society for Clinical Investigation

    George Kalliolias, Keisuke Horiuchi

  10. The interferon signature andSTAT1expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment

    Article • Arthritis & Rheumatism, September 2012, Wiley

    George Kalliolias

  11. Churg–Strauss Syndrome with Eosinophilic Myocarditis

    Article • HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery, June 2012, Springer Science + Business Media

    George Kalliolias

  12. Type I interferons as biomarkers in autoimmune diseases

    Article • Biomarkers in Medicine, April 2012, Future Medicine

    George Kalliolias

  13. Suppression of TNF-  and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27

    Article • The Journal of Immunology, October 2010, The American Association of Immunologists

    George Kalliolias

  14. Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins

    Article • Immunity, April 2010, Elsevier

    George Kalliolias

  15. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages

    Article • Proceedings of the National Academy of Sciences, January 2010, Proceedings of the National Academy of Sciences

    George Kalliolias

  16. Overview of the biology of type I interferons

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    George Kalliolias

  17. A new tool for detection of type I interferon activation in systemic lupus erythematosus

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    George Kalliolias

  18. IL-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of NFATc1 and suppressing proximal RANK signaling

    Article • Arthritis & Rheumatism, January 2010, Wiley

    George Kalliolias

  19. Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy

    Article • European Journal of Cancer Care, September 2008, Wiley

    George Kalliolias

  20. IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38

    Article • The Journal of Immunology, April 2008, The American Association of Immunologists

    George Kalliolias

  21. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

    Article • Expert Opinion on Investigational Drugs, March 2008, Informa Healthcare

    George Kalliolias

  22. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

    Article • Annals of the Rheumatic Diseases, January 2007, BMJ

    George Kalliolias

  23. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease

    Article • Rheumatology International, September 2006, Springer Science + Business Media

    George Kalliolias

  24. Hippocrates and Genomic Medicine

    Article • Archives of Medical Research, January 2006, Elsevier

    George Kalliolias

  25. Pharmacogenetic Principles in the Hippocratic Writings

    Article • The Journal of Clinical Pharmacology, November 2005, Wiley

    George Kalliolias

  26. Of Temples and Plane Trees: the Hippocratic Legacy as Collective Memory

    Article • HORMONES, January 2005, Hellenic Endocrine Society

    George Kalliolias